EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo

Santiago José Martínez, María Cristina Vanrell, Xiaomo Li, Carolina Carrillo, David M Engman, Patricia Silvia Romano

Frontiers in Cellular and Infection Microbiology · 30.03.2026 · 16

DOI: 10.3389/fcimb.2026.1794141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 30.03.2026. Verfasst von Santiago José Martínez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biología de Trypanosoma cruzi y la célula hospedadora - Instituto de Histología y Embriología "Dr. Mario H. Burgos", IHEM-CONICET- Uni…. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Nitroimidazoles, Eflornithine, Chagas Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi , is currently a global health problem. Its multiple forms of transmission, which favor the spread of the infection, and the limited treatment options—still restricted to only two drugs—highlight the urgent need for research and development in the field. Despite certain disadvantages, the potent trypanocidal activity of benznidazole (BNZ) and nifurtimox explains their continued use notwithstanding their high toxicity. Reducing BNZ doses through combination with another antiparasitic drug is an attractive strategy to improve tolerability while maintaining efficacy. In this work, we explored the anti- T. cruzi effect of BNZ in combination with difluoromethylornithine (DFMO), a repurposed drug currently used for the treatment of certain cancers and other pathologies. Our data showed that DFMO increases parasite susceptibility to BNZ, reducing the IC50 by half compared to BNZ monotherapy in vitro across strains from three different T. cruzi genetic lineages. Subsequently, we examined the effect of the combination in vivo . We found that mice treated with a 10-fold lower dose of BNZ combined with DFMO displayed a lower parasitemia peak and reduced tissue parasitosis during the acute stage, as well as less parasite reactivation in organs after immunosuppression in the chronic stage, compared to BNZ monotherapy. Overall, these findings support the BNZ/DFMO combination as a proof of concept for Chagas disease therapy, offering a viable strategy to mitigate BNZ-related toxicity through dose reduction without compromising therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziNitroimidazolesEflornithineChagas DiseaseTrypanocidal AgentsAnimalsMiceDisease Models, AnimalParasitemiaInhibitory Concentration 50Drug SynergismFemaleDrug Therapy, Combination

Stichwörter der Autor:innen

Chagas diseaseTrypanosoma cruzibenznidazolecombined therapiesdifluoromethylornithine

Substanzen

NitroimidazolesbenzonidazoleEflornithineTrypanocidal Agents

Autor:innen und Institutionen

  • Laboratorio de Biología de Trypanosoma cruzi y la célula hospedadora - Instituto de Histología y Embriología "Dr. Mario H. Burgos", IHEM-CONICET- Universidad Nacional de Cuyo, Mendoza, Argentina.
  • Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Área Biología Celular y Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
  • Instituto de Ciencia y Tecnología Dr. César Milstein, ICT Milstein-CONICET, Buenos Aires, Argentina.

Zitieren

APA

Martínez, S. J., Vanrell, M. C., Li, X., Carrillo, C., Engman, D. M., & Romano, P. S. (2026). New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1794141

Vancouver

Martínez SJ, Vanrell MC, Li X, Carrillo C, Engman DM, Romano PS. New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1794141

BibTeX
@article{Martnez2026,
  author = {Martínez, Santiago José and Vanrell, María Cristina and Li, Xiaomo and Carrillo, Carolina and Engman, David M and Romano, Patricia Silvia},
  title = {New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on Trypanosoma cruzi in vitro and in vivo},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1794141}
}
Kostenlos starten →